Literature DB >> 8395367

Homozygous familial amyloidosis, Finnish type: demonstration of glomerular gelsolin-derived amyloid and non-amyloid tubular gelsolin.

C P Maury1.   

Abstract

The immunohistochemical findings in the kidneys of two sisters with homozygous familial amyloidosis of Finnish type, an autosomal dominant disorder of gelsolin catabolism, is described. The disease, manifesting with nephrotic syndrome and end-stage renal failure was characterized by heavy glomerular deposits of gelsolin-derived amyloid. Immunostaining also revealed the presence of gelsolin in the tubular epithelium that was Congo-red negative. It is concluded that homozygous Finnish amyloidosis leads to a severe nephropathy due to the deposition of fragments of mutant gelsolin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395367

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

Review 1.  Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention.

Authors:  James P Solomon; Lesley J Page; William E Balch; Jeffery W Kelly
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-02-24       Impact factor: 8.250

2.  Late onset lattice corneal dystrophy with systemic familial amyloidosis, amyloidosis V, in an English family.

Authors:  H S Stewart; R Parveen; A E Ridgway; R Bonshek; G C Black
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

3.  Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type).

Authors:  C P Maury; M Liljeström; G Boysen; T Törnroth; A de la Chapelle; E L Nurmiaho-Lassila
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

4.  Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases.

Authors:  Samar M Said; Sanjeev Sethi; Anthony M Valeri; Nelson Leung; Lynn D Cornell; Mary E Fidler; Loren Herrera Hernandez; Julie A Vrana; Jason D Theis; Patrick S Quint; Ahmet Dogan; Samih H Nasr
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-23       Impact factor: 8.237

5.  Homozygosity for the E526V Mutation in Fibrinogen A Alpha-Chain Amyloidosis: The First Report.

Authors:  Isabel Tavares; Luísa Lobato; Carlos Matos; Josefina Santos; Paul Moreira; Maria João Saraiva; António Castro Henriques
Journal:  Case Rep Nephrol       Date:  2015-06-23

6.  Clinical, histopathological, and in silico pathogenicity analyses in a pedigree with familial amyloidosis of the Finnish type (Meretoja syndrome) caused by a novel gelsolin mutation.

Authors:  Jesus Cabral-Macias; Leopoldo A Garcia-Montaño; Mario Pérezpeña-Díazconti; Marisa-Cruz Aguilar; Guillermo Garcia; Carlos I Vencedor-Meraz; Enrique O Graue-Hernandez; Oscar F Chacón-Camacho; Juan C Zenteno
Journal:  Mol Vis       Date:  2020-05-02       Impact factor: 2.367

7.  D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile.

Authors:  Sophie Valleix; Guglielmo Verona; Noémie Jourde-Chiche; Brigitte Nédelec; P Patrizia Mangione; Frank Bridoux; Alain Mangé; Ahmet Dogan; Jean-Michel Goujon; Marie Lhomme; Carolane Dauteuille; Michèle Chabert; Riccardo Porcari; Christopher A Waudby; Annalisa Relini; Philippa J Talmud; Oleg Kovrov; Gunilla Olivecrona; Monica Stoppini; John Christodoulou; Philip N Hawkins; Gilles Grateau; Marc Delpech; Anatol Kontush; Julian D Gillmore; Athina D Kalopissis; Vittorio Bellotti
Journal:  Nat Commun       Date:  2016-01-21       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.